Evidence map›Paper›PMID 31642999›Full record

ArticleLasers in medical science2020

The study of effect and mechanism of 630-nm laser on human lung adenocarcinoma cell xenograft model in nude mice mediated by hematoporphyrin derivatives.

Cunzhi Lin, Yuanyuan Zhang, Jun Wang, Aihua Sui, Lulu Xiu, Xinhong Zhu

Abstract read
PubMed Publisher
In one paragraph

Article in Lasers in medical science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Cunzhi LinDepartment of Respiration, The Affiliated Hospital of Qingdao University, Qingdao, 266003, China.
Yuanyuan ZhangDepartment of Respiration, The Affiliated Hospital of Qingdao University, Qingdao, 266003, China.
Jun WangDepartment of Dermatology, The Affiliated Hospital of Qingdao University, Qingdao, 266003, China.
Aihua SuiCentral laboratory, The Affiliated Hospital of Qingdao University, Qingdao, 266003, China.
Lulu XiuDepartment of Respiration, The Affiliated Hospital of Qingdao University, Qingdao, 266003, China.
Xinhong ZhuDepartment of International Medicine, Qingdao Municipal Hospital, Qingdao, 266071, China. hongdoc@126.com.
Affiliated Hospital of Qingdao University · CNQingdao Municipal Hospital · CNQingdao University · CN

Funding

Huangdao Science and Technology Bureau Project of Qingdao 2014-1-77
6 · The paper itself

Abstract

To investigate the effect and mechanism of 630-nm laser on human lung adenocarcinoma cell xenograft model in nude mice mediated by hematoporphyrin derivatives (HPD) and provide theoretical basis for clinical photodynamic therapy (PDT). Human lung adenocarcinoma cell xenograft model in nude mice was established and randomly divided into four groups: control group, pure photosensitizer group, pure irradiation group, and photodynamic treatment group. The tumor volume growth was compared, and the tumor growth inhibition rate was calculated. HE staining was used for routine pathological observation of tumor sections, and gross conditions of cells, interstitium, and blood vessels in several groups of tumor tissues were observed. TUNEL staining was used to observe and compare the apoptosis induced by photodynamic therapy. Real-time fluorescence quantitative reverse transcription polymerase chain reaction (RT-PCR) was used to detect the expression level of angiogenesis-related factors VEGF, HIF-1α and apoptosis-related factors Bax and Bcl-2 mRNA in the transplanted tumor tissues. Western blot was employed to detect the expression of angiogenesis-related proteins VEGF, HIF-1α and apoptosis-related proteins Bax, Caspase-3, and Bcl-2. Compared with the other three groups, the tumor growth inhibition rate of the photodynamic treatment group was significantly increased and the difference was statistically significant (P < 0.05). HE staining showed that the animal model of lung adenocarcinoma A549 was successfully established. TUNEL staining revealed that more apoptotic cells were found in the photodynamic treatment group, and the apoptosis index was calculated. Compared with the other three groups, the difference was statistically significant (P < 0.05). RT-PCR results showed that compared with the other three groups, the mRNA expressions of VEGF, HIF-1α, and Bcl-2 in the photodynamic treatment group decreased, while the expression of Bax mRNA increased(P < 0.05), and the differences were statistically significant. Western blot results showed that protein expressions of VEGF, HIF-1α, and Bcl-2 decreased in the photodynamic treatment group, while protein expression level of Bax and Caspase-3 increased (P < 0.05), indicating statistically significant differences. The 630-nm laser mediated by hematoporphyrin derivatives can significantly inhibit the growth of human lung adenocarcinoma xenograft tumor in nude mice, the mechanism of which is related to the inhibition of tumor angiogenesis by down-regulating VEGF and HIF-1α gene expression, and the promotion of tumor apoptosis by up-regulating Bax, Caspase-3, and down-regulating Bcl-2 gene expression.

Indexed as

Laser TherapyXenograft Model Antitumor AssaysAdenocarcinoma of LungAnimalsApoptosisCell ProliferationFemaleGene Expression Regulation, NeoplasticHematoporphyrin DerivativeHumansLung NeoplasmsMice, Inbred BALB CMice, NudeNeoplasm ProteinsPhotochemotherapyPhotosensitizing AgentsHematoporphyrin DerivativeNeoplasm ProteinsPhotosensitizing AgentsRNA, MessengerAngiogenesisAnimal modelsApoptosisLung adenocarcinomaPhotodynamic therapy

Identifiers

PMID31642999
OpenAlexW2982127558

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.